Revised Atlanta Classification - Acute Pancreatitis

Summarized by: Niharika Shahi, M.D.

Reviewed by: Prasaanthan Gopee-Ramanan, M.D.

Original publication details

Authors: Ruedi F. Thoeni

DOI: 10.1148/radiol.11110947

Reference: Thoeni, R. (2012). The Revised Atlanta Classification of Acute Pancreatitis: Its Importance for the Radiologist and Its Effect on Treatment. Radiology, 262(3), 751-764.

Acute pancreatitis (with or without chronic pancreatitis) is clinically defined by A & B +/- C:

A

Abdominal pain suggestive of pancreatitis (typically epigastric pain radiating to back)

&

B

Serum amylase and lipase levels ≥ 3x normal (imaging is to be used if elevated values are < 3x normal)

+/-

C

Characteristic findings on CT, MRI, or transabdominal ultrasound


Early phase

Within 1st week of onset

Progression from early inflammation → variable degrees of peripancreatic edema and ischemia → resolution or permanent necrosis and liquefaction


Late phase

After 1st week of onset; may extend for weeks to months

Characterized by increasing necrosis, infection, and/or persistent multi-organ failure


Role of contrast-enhanced CT in pancreatitis

(ideally > 72 hours after symptom onset to assess complications related to pancreatitis)

CT should be repeated when the clinical picture drastically changes (e.g. sudden onset of fever, decrease in hematocrit, or sepsis) 

CT to guide catheter placement for drainage and assess success of treatment in patients who have undergone percutaneous drainage or other interventions

If first episode of pancreatitis in patients > 40 years of age and no identifiable cause for pancreatitis, contrast-enhanced CT should be used to exclude a possible neoplasm 

Report considerations

Pancreas or surrounding fat necrosis?

Parenchymal or surrounding collections?

Gallstones?

Biliary dilatation?

Venous (or arterial) thrombosis?

Aneurysms?

Ascites?

GI tract inflammation?

MRI and US reserved for special indications

MRI → detect choledocholithiasis not visualized on contrast-enhanced CT images and to further characterize collections for the presence of non-liquefied material (solid and semisolid components, usually pancreatic and extra-pancreatic debris and necrotic fatty tissue)

Patients with contraindication to contrast-enhanced CT (e.g. allergy to iodinated intravenous contrast agents or pregnancy)

US used to assess presence of stones in gallbladder [higher sensitivity than CT]

*less accurate than contrast-enhanced CT or MR imaging for visualizing distal common bile duct stones and has the disadvantage of being operator dependent

CT features of different types of pancreatitis

Interstitial edematous pancreatitis (IEP) 

Localized or diffuse enlargement of the pancreas, with normal homogeneous enhancement or slightly heterogeneous enhancement of pancreatic parenchyma related to edema 

Peripancreatic and retroperitoneal tissue may appear normal or with mild inflammatory changes (“mistiness”) with varying amounts of peripancreatic fluid 

Contrast-enhanced CT performed 5–7 days after acute onset to definitively characterize as either IEP or ill-defined necrosis

Necrotizing Pancreatitis

Three forms of acute necrotizing pancreatitis, depending on location; all three types can be sterile or infected

Pancreatic parenchymal necrosis alone — < 5% of patients; appears on contrast-enhanced CT as lack of parenchymal enhancement

Peripancreatic necrosis alone — ~ 20% of patients; heterogeneous areas of non-enhancement containing non-liquefied components, commonly located in the retroperitoneum and lesser sac

Pancreatic parenchymal necrosis with peripancreatic necrosis — most common type, seen in 75%–80% of patients with acute necrotizing pancreatitis; may involve main pancreatic duct

Pancreatic and Peripancreatic Collections

Acute peripancreatic fluid collection (APFC)

Absence of necrosis; IEP can be associated with APFC and, over time, with pancreatic pseudocysts 

Without non-liquefied components arising in patients with IEP

Caused by pancreatic and peripancreatic inflammation or by rupture of one or more small peripheral pancreatic side duct branches

Conform to the anatomic boundaries of retroperitoneum (especially the anterior pararenal fascia), are usually seen immediately next to the pancreas, and have no discernable wall

Most are reabsorbed spontaneously within few weeks and do not become infected drainage or aspiration of fluid could introduce infection 

Pseudocyst

Within 4 weeks from onset of acute IEP, an APFC may gradually transition into a pseudocyst (complication of acute pancreatitis in approximately 10%–20% of cases) 

Well-circumscribed, usually round or oval peripancreatic fluid collections of homogeneously low attenuation surrounded by well-defined enhancing wall (capsule consisting of fibrous or granulation tissue)

Infected pseudocyst is diagnosed on CT images by the presence of gas within the pseudocyst or, in absence of gas, by means of fine-needle aspiration (FNA) with Gram staining and culture for bacteria or fungal organisms 

A pseudocyst can be treated effectively by draining the fluid in most cases

Acute necrotic collection (ANC)

Presence of necrosis; necrotizing pancreatitis (all three forms) can be associated with ANC and, over time, with walled-off necrosis

All of these collections can be sterile or infected. 

Contains both fluid and necrotic material of various amounts (some of which are loculated)

Walled off necrosis (WON)

Over time (usually at or after 4 weeks), the ANC matures and develops a thickened non-epithelialized wall between the necrosis and the adjacent tissue

In contradistinction to a pseudocyst, WON contains necrotic pancreatic parenchyma or necrotic fat

Most non-liquefied components need to be removed by means of a percutaneous image-guided approach, a laparoscopic or endoscopic procedure, or surgery

Complications

All four types of pancreatic fluid collections can be sterile or infected

Collections that contain non-liquefied material are more likely to become infected

Treatments


IEP

Usually self-limited, supportive measures alone suffice 

Most APFCs resolve spontaneously or mature into pseudocysts, majority of pseudocysts disappear spontaneously over time and do not require any treatment 

Necrotizing Pancreatitis

Necrotizing pancreatitis requires close monitoring, and minimally invasive radiologic procedures or laparoscopic, endoscopic, or surgical techniques are often needed to improve outcome

Sterile Pancreatic Necrosis

CT is performed every 7–10 days to look at evolution of pancreatic necrosis and assess evidence of infection (air bubbles) and complications such as increased peripancreatic necrotic collections or hemorrhage

Patients who have clinical instability (e.g. tachycardia, leukocytosis, fever, organ failure), and do not show radiologic evidence of infection, may benefit from FNA of the necrosis to rule out infected necrosis

Follow-up CT is used to ensure adequate drainage has been achieved, and additional larger catheters may have to be placed in cases of residual necrotic fluid

Infected Pancreatic Necrosis

Generally treated with surgical debridement and antibiotics


Citation


Thoeni, R. (2012). The Revised Atlanta Classification of Acute Pancreatitis: Its Importance for the Radiologist and Its Effect on Treatment. Radiology, 262(3), 751-764.